Subclinical zinc deficiency in Alzheimer's disease and Parkinson's disease

American Journal of Alzheimer's Disease and other Dementias

Volumn 25, Issue 7, 2010, Pages 572-575

  Brewer, George J ^a,b   Kanzer, Steve H ^b   Zimmerman, Earl A ^c   Molho, Eric S ^c   Celmins, Dzintra F ^c   Heckman, Susan M ^c   Dick, Robert ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Adeona Pharmaceuticals   (United States)

^c ALBANY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Parkinson's disease; zinc; zinc deficiency

Indexed keywords

COPPER; CREATININE; ZINC;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; FEMALE; HUMAN; MALE; NUTRITIONAL STATUS; PARKINSON DISEASE; ZINC BLOOD LEVEL; ZINC DEFICIENCY; ZINC URINE LEVEL;

EID: 77957940736     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/1533317510382283     Document Type: Article

References (27)

1. Prasad AS Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontol. 2008 ; 43 (5). 370-377.
2. Brewer G., Kanzer SH, Zimmerman E., Heckman S. Sub-clinical zinc deficiency found in Alzheimer's disease. Alzheimers Dement. 2009 ; 5: e22.
3. Baum L., Chan IH, Cheung SK, et al. Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability. Biometals. 2010 ; 23 (1). 173-179.
4. Prasad AS, Meftah S., Abdallah J., et al. Serum thymulin in human zinc deficiency. J Clin Invest. 1988 ; 82 (4). 1202-1210.
5. Prasad AS Zinc deficiency: its characterization and treatment. Met Ions Biol Syst. 2004 ; 41: 103-137.
6. Perry G., Taddeo MA, Petersen RB, et al. Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease. Biometals. 2003 ; 16 (1). 77-81.
7. Newsome DA, Swartz M., Leone NC, Elston RC, Miller E. Oral zinc in macular degeneration. Arch Opthamol. 1988 ; 106 (2). 192-198.
8. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan EM Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 ; 34 (7). 939-944.
9. Morris JC The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993 ; 43 (11). 2412-2414.
10. Folstein MF, Folstein SE, McHugh PR " Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 ; 12 (3). 189-198.
11. Sheikh JI, Yesabage JA Geriatric Depression Scale (GDS): Recent Evidence and Development of a Shorter Version. Clinical Gerontology: A Guide to Assassment and Intervention. New York: The Haworth Press ; 1986.
12. Rosen WG, Mohs RC, Davis KL A new rating scale for Alzheimer's disease. Am J Psychiatry. 1984 ; 141 (11). 1356-1364.
13. Duke OARS. Multi-Dimensional Functional Assessment: The OARS Methodology. Durham, NC: Duke University Center for the Study of Aging and Human Development ; 1978.
14. Daniel SE, Lees AJ Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl. 1993 ; 39: 165-172.
15. Fahn S., Elton RL Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Health Care Information; 1987: 153-164.
16. Hoehn MM, Yahr MD Parkinsonism: onset, progression and mortality. Neurology. 1967 ; 17 (5). 427-442.
17. Heinegard D., Tiderstrom G. Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta. 1973 ; 43 (3). 305-310.
18. Constantinides J. Treatment of Alzheimer's disease by zinc compounds. Drug Dev Res. 1992 ; 27: 1-14.
19. Izumi Y., Auberson YP, Zorumski CF Zinc modulates bidirectional hippocampal plasticity by effects on NMDA receptors. J Neurosci. 2006 ; 26 (27). 7181-7188.
20. Strozyk D., Launer LJ, Adlard PA, et al. Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid. Neurobiol Aging. 2009 ; 30 (7). 1069-1077.
21. Molina JA, Jimenez-Jimenez FJ, Aguilar MV, et al. Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J Neural Transm. 1998 ; 105 (4-5). 479-488.
22. Jeandel C., Nicolas MB, Dubois F., Nabet-Belleville F., Penin F., Cuny G. Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology. 1989 ; 35 (5-6). 275-282.
23. Dong J., Robertson JD, Markesbery WR, Lovell MA Serum zinc in the progression of Alzheimer's disease. J Alzheimer Dis. 2008 ; 15 (3). 443-450.
24. Prasad AS, Fitzgerald JT, Hess JW, Kaplan J., Pelen F., Dardenne M. Zinc deficiency in elderly patients. Nutrition. 1993 ; 9 (3). 218-224.
25. Religa D., Strozyk D., Cherny RA, et al. Elevated cortical zinc in Alzheimer disease. Neurology. 2006 ; 67 (1). 69-75.
26. Cornett CR, Markesbery WR, Ehmann WD Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology. 1998 ; 19 (3). 339-345.
27. Deibel MA, Ehmann WD, Markesbery WR Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J Neurol Sci. 1996 ; 143 (1-2). 137-142.